GlassScriptPhysician profile
Brian D Brehm
NPI 1811190028
$1,530.78
in general payments reported to CMS, 2019-2025
22 companies · $771 in 2025
The $771 reported for 2025 was more than what 75% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $170 · 2022: $115 · 2023: $57.09 · 2024: $417 · 2025: $771.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,245.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,245.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $182.07 | 2025 | Sapien 3 Ultra Resilia |
| Inspire Medical Systems, INC. | $129.88 | 2025 | Inspire |
| Glaxosmithkline, LLC. | $121.17 | 2024 | Shingrix |
| Astrazeneca Pharmaceuticals LP | $121.17 | 2025 | Airsupra |
| Sanofi-Aventis U.S. LLC | $121.17 | 2025 | |
| Abbott Laboratories | $102.15 | 2024 | Freestyle Libre 3 |
| Tactile Systems Technology INC | $99.57 | 2021-2023 | Entre Plus, Flexitouch Plus |
| Lexicon Pharmaceuticals, INC. | $90.72 | 2024 | Inpefa |
| Janssen Pharmaceuticals, INC | $87.04 | 2021-2022 | |
| Kci USA, INC. | $86.15 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $78.19 | 2025 | Jardiance |
| Smith+Nephew, INC. | $77.50 | 2024-2025 | Collagenase Santyl |
| Kerecis Limited | $42.90 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Solventum Corporation | $37.44 | 2024-2025 | V.A.C.Ulta, Prevena, V.A.C. Veraflo Cleanse Choice |
| Csl Behring | $26.96 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $25.36 | 2025 | Transorb |
| Acera Surgical, INC. | $21.39 | 2024 | Restrata Wound Matrix |
| Integra Lifesciences Corporation | $21.02 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Innocoll Pharmaceuticals Limited | $17.18 | 2021 | |
| Arjo INC. | $16.01 | 2025 | |
| Medline Industries LP | $13.86 | 2023 | Medline Industries, INC., Z-Guard |
| E.R. Squibb & Sons, L.L.C. | $11.88 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Brehm listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.